MedPath

Treatment of Periodontal Intra-bony Defects With a Volume Stable Collagen Matrix or Deproteinized Bovine Bone Mineral With 10% Collagen

Not Applicable
Not yet recruiting
Conditions
Periodontal Diseases
Registration Number
NCT06676826
Lead Sponsor
University of Bern
Brief Summary

To compare the healing of intrabony periodontal defects treated with either open flap debridement and a volume-stable collagen matrix (VCMX) or a deproteinized bovine bone mineral with 10% collagen. The results will shed light on the clinical potential of VCMX in regenerative periodontal surgery and help to develop new treatment strategies.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Clinical attachment level (CAL) change12 months

Clinical attachment level (CAL) change in mm: the distance from the cemento-enamel junction to the bottom of the clinical periodontal pocket is being measured

Secondary Outcome Measures
NameTimeMethod
Microbiological analysis1, 3, 12 weeks

Quantification of the concentration of host-derived biomarkers (interleukin-1beta (IL-1b), IL-10, matrix-metalloproteinase- 8(MMP-8)) and periodontal bacterial species by means of gingival crevicular fluid and the biofilm sampling

Bleeding on probing (BoP)Baseline, 12 months

Assessment of number of bleeding spots (percentage 0-100%) upon gentle probing of PPD at each test and control tooth site

Pocket probing depth (PPD)Baseline, 12 months

With a periodontal probe with mm markings, the distance between the gingival margin and the bottom of the pocket will be measured

Trial Locations

Locations (1)

University of Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath